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Background: Fournier's gangrene is a rapidly progressing, life-threatening necrotizing soft tissue infec-
tion that affects the genitalia and perineum. The aim of this study was to analyze the clinical charac-
teristics of elderly patients with Fournier's gangrene and compare them to those of younger patients
with Fournier's gangrene.
Methods: We conducted a retrospective study of patients diagnosed as having Fournier's gangrene from
1997 to 2012. Clinical data were compared between elderly (i.e., 65 years or older) and younger adult
patients (i.e., younger than 65 years), and between patients who died and patients who survived.
Results: Seventy-three cases of Fournier's gangrene were collected (with most from 69 males). There
were 24 elderly patients and 50 younger adult patients. A larger percentage of elderly patients presented
with shock (p ¼ 0.015) and elderly patients had longer intensive care unit (ICU) stays (p ¼ 0.014). The
mortality rate was also higher in elderly patients, but the difference was not statistically signiﬁcant
(p ¼ 0.176). Twelve patients of the 74 patients died. Patients who died had a higher Fournier's Gangrene
Severity Score (p < 0.001) and longer ICU stay (p ¼ 0.030), compared to patients who survived. Patients
who died did not have more comorbidities, but a larger percentage of them presented with shock
(p < 0.001).
Conclusion: This study showed that the clinical characteristics of elderly Fournier's gangrene patients
were not different from those of younger patients, and that elderly patients did not have more severe
disease at presentation. However, a signiﬁcant percentage of elderly patients presented with shock, and
most patients who eventually died also had shock at presentation. We therefore suggest intensive
monitoring of vital signs and adequate cardiovascular support, especially in the elderly.
Copyright © 2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Fournier's gangrene (FG) is a rapidly progressing, life-
threatening necrotizing soft tissue infection that affects the geni-
talia and perineum. In 1764, Baurienne ﬁrst described it1. Fournier's
gangrene was named after Jean Alfred Fournier, who described the
clinical features of the disease in 5 healthy young men2,3.
At the time of diagnosis, 30e50% of patients do not have iden-
tiﬁable risk factors4; however, previously reported predisposing
factors for FG include age, diabetes mellitus, hypertension, immu-
nosuppression, chronic renal failure, alcoholism, obesity, cachexia,lare no conﬂicts of interest.
rtment of Urology, Mackay
an North Road, Taipei 104,
u).
tric Emergency & Critical Care Mepulmonary diseases, and systemic disorders5e11. The aim of this
study was to analyze the clinical and epidemiological characteris-
tics of elderly patients with FG and to compare these characteristics
to those of younger patients.
2. Patients
We conducted a retrospective study of patients admitted from
1997 to 2012 to the urology and colorectal surgery wards of Mackay
Memorial Hospital (Taipei, Taiwan). Included in this study were all
adult patients who had soft tissue infections that involve the
scrotum, perineum, and perianal areas and had radiological or
physical ﬁndings of subcutaneous gas accumulation, who under-
went surgical management, and whose disease was pathologically
conﬁrmed.
Data collected included age; sex; vital signs at presentation;
comorbidities such as diabetes, hypertension, previous stroke, and
alcoholism; hemogram; serum biochemistry; the number ofdicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Comparison of the clinical characteristics between elderly patients and younger
adult patients.
Elderly (n ¼ 23) Younger adults (n ¼ 50) p
Male sex, n (%) 20 (86.96) 49 (98.00) 0.090
Diabetes, n (%) 12 (54.55) 33 (67.35) 0.442
Hypertension, n (%) 12 (54.55) 12 (24.49) 0.028
Alcoholism, n (%) 1 (4.55) 7 (14.00) 0.421
Stroke, n (%) 2 (9.09) 3 (6.00) 0.638
T score 0.24 ± 0.70 0.20 ± 0.64 0.824
HR score 0.27 ± 0.70 0.67 ± 1.05 0.064
RR score 0.10 ± 0.30 0.08 ± 0.45 0.899
Shock, n (%) 10 (55.56) 10 (20.83) 0.015
Na score 0.19 ± 0.60 0.64 ± 0.94 0.022
K score 0.29 ± 0.71 0.31 ± 0.78 0.893
Cr score 1.80 ± 1.61 0.79 ± 1.35 0.006
Hct score 0.82 ± 1.18 0.58 ± 0.95 0.367
WBC score 0.73 ± 0.88 0.94 ± 0.89 0.352
Bic score 2.00 ± 1.25 2.29 ± 1.68 0.654
FGSI score 4.91 ± 4.08 4.70 ± 4.04 0.835
Hospital stay, d 20.48 ± 11.70 23.68 ± 16.92 0.415
ICU stay, d 4.47 ± 5.40 1.48 ± 3.92 0.014
Operation times 2.32 ± 1.13 2.94 ± 2.28 0.127
Reconstruction, n (%) 5 (22.73) 20 (40.00) 0.250
Death, n (%) 6 (26.09) 6 (12.00) 0.176
Data are presented as mean ± standard deviation, unless otherwise indicated.
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tion; length of intensive care unit (ICU) stay and overall hospital
stay; and outcome. The Fournier's Gangrene Severity Index (FGSI)
was calculated for each patient. The FGSI, which was developed by
Laor et al12, is a numerical score obtained from the patient's vital
signs and laboratory parameters at presentation such as body
temperature, heart rate, respiration rate, sodium, potassium,
creatinine, white blood cell count, hematocrit, and sodium bicar-
bonate. Parameters were scored from 0 to þ4, depending on their
severity at presentation, as previously described12.
Variables were compared between elderly patients (i.e., 65 years
or older) and younger adult patients (i.e., less than 65 years), and
between patients who died and patients who survived.
The Student t test and Chi-square test were performed for the
statistical analysis of quantitative data and categorical variables,
respectively. The Fisher’s exact test was used instead when the
expected values were below 5 in any cell of a contingency table.
Values of p < 0.05 were considered statistically signiﬁcant. Uni-
variate logistic regression analysis was performed to determine the
association of patient risk factors and death from FG. The crude
odds ratio (OR) and 95% conﬁdence interval (95% CI) were obtained.
This study was approved by the Institutional Review Board of
Mackay Memorial Hospital.Bic ¼ bicarbonate; Cr ¼ creatinine; FGSI ¼ Fournier's Gangrene Severity Index;
Hct ¼ hematocrit; HR ¼ heart rate; ICU ¼ intensive care unit; K score ¼ potassium
score; Na ¼ sodium; RR ¼ respiratory rate; T score ¼ temperature score;
WBC ¼ white blood cell count.
Table 2
Comparison of the clinical parameters between patients of all ages who died and
patients who survived.
Died (n ¼ 12) Survived (n ¼ 61) p
Age 60.92 ± 14.11 56.00 ± 13.88 0.267
Male sex 11 (91.67) 58 (95.08) 0.521
Diabetes, n (%) 10 (83.33) 35 (59.32) 0.189
Hypertension, n (%) 5 (41.67) 19 (32.20) 0.524
Alcoholism, n (%) 3 (25.00) 5 (8.33) 0.123
Stroke, n (%) 1 (8.33) 4 (6.67) 1.000
T score 0.33 ± 0.89 0.17 ± 0.60 0.481
HR score 1.00 ± 1.28 0.46 ± 0.88 0.077
RR score 0.33 ± 0.89 0.03 ± 0.18 0.270
Shock, n (%) 10 (90.91) 10 (18.18) < 0.001
Na score 0.67 ± 0.98 0.46 ± 0.85 0.470
K score 0.50 ± 1.00 0.26 ± 0.70 0.326
Cr score 2.42 ± 1.62 0.75 ± 1.31 < 0.001
Hct score 0.67 ± 0.98 0.65 ± 1.04 0.959
WBC score 1.00 ± 1.04 0.85 ± 0.86 0.596
Bic score 3.13 ± 1.46 1.69 ± 1.30 0.023
FGSI score 9.00 ± 4.84 3.93 ± 3.29 < 0.001
Hospital stay, d 13.92 ± 12.65 24.39 ± 15.46 0.031
ICU stay, d 5.20 ± 5.31 1.82 ± 4.26 0.030
Operation times 2.09 ± 1.45 2.87 ± 2.09 0.241
Reconstruction, n (%) 2 (16.67) 23 (38.33) 0.196
Data are presented as mean ± standard deviation, unless otherwise indicated.
Bic ¼ bicarbonate; Cr ¼ creatinine; FGSI ¼ Fournier's Gangrene Severity Index;
Hct ¼ hematocrit; HR ¼ heart rate; ICU ¼ intensive care unit; K score ¼ potassium
score; Na ¼ sodium; RR ¼ respiratory rate; T score ¼ temperature score;
WBC ¼ white blood cell count.3. Results
Seventy-three cases of FG were collected. Of these, 69 (94.5%)
patients were male. There were 23 elderly patients (mean age,
73.6 ± 5.7 years) and 50 younger adult patients (mean age,
49.1 ± 8.8 years). Elderly patients had higher creatinine scores and
lower sodium scores; however, the FGSI score overall was not
statistically different between elderly patients and younger adult
patients (Table 1). A larger percentage of elderly patients presented
with shock, compared to younger patients (55.6% vs. 20.8%,
respectively; p ¼ 0.015) and elderly patients had longer ICU stays,
compared with younger patients (4.5 ± 5.4 days vs. 1.5 ± 3.9 days,
p ¼ 0.014). The percentage of patients who died of the disease was
also higher in the elderly patients than in the younger patients, but
the difference was not statistically signiﬁcant (26.1% vs. 12.0%,
respectively; p ¼ 0.176). The length of hospitalization and number
of operations required were similar between the two groups.
Twelve (16.4%) patients of the 73 patients died. A comparison of
patients who died to patients who survived showed that patients
who died had a higher FGSI score (9.0 ± 4.8 vs. 3.9 ± 3.3, p < 0.001),
a longer ICU stay (5.2 ± 5.3 vs. 1.8 ± 4.3 days, p ¼ 0.030), but a
shorter hospitalization stay (13.9 ± 12.7 vs. 24.4 ± 15.5, days
p ¼ 0.031) (Table 2). A signiﬁcantly larger percentage of patients
who died presented with shock, compared to the patients who
survived (90.9% vs. 18.2%, respectively; p < 0.001). However, pa-
tients who died did not have more comorbidities such as hyper-
tension, diabetes, previous stroke, or alcoholism, compared to
patients who survived.
An analysis of renal function at presentation showed that the
serum creatinine levels were signiﬁcantly higher in elderly patients
than in younger pts (1.80 ± 1.61 vs. 0.79 ± 1.35, respectively;
p ¼ 0.006) and in patients who died than in patients who survived
(2.42 ± 1.62 vs. 0.75 ± 1.31, respectively; p < 0.001) (Tables 1, 2).
A further analysis of the laboratory values of elderly patients
showed that only the bicarbonate score was signiﬁcantly higher in
patients who died than in patients who survived (3.3 ± 1.2 vs.
1.4 ± 0.8, respectively; p ¼ 0.015) (Table 3). The FGSI score was
higher in elderly patients who died than in patients who survived,
but the difference had only borderline statistical signiﬁcance
(7.7 ± 4.6 vs. 3.9 ± 3.5, respectively; p ¼ 0.052). Five patients of the10 elderly patients who had a recorded episode of shock at pre-
sentation died.
Eleven patients had a FGSI score of 9 or greater and 62 patients
had a FGSI score of less than 9. A signiﬁcantly higher percentage of
patients with a FGSI score of 9 or greater died, compared with
patients with a FGSI score of less than 9 (45.5% vs. 11.3%, respec-
tively; p ¼ 0.014). A further analysis of elderly patients showed a
higher mortality rate in elderly patients with a FGSI score of 9 or
greater than in elderly patients with a FGSI score of less than 9,
Table 3
Comparison of the clinical characteristics between elderly patients who died and
patients who survived.
Died (n ¼ 6) Survived (n ¼ 17) p
Male sex, n (%) 5 (83.33) 15 (88.24) 1.000
Diabetes, n (%) 5 (83.33) 7 (48.75) 0.162
Hypertension, n (%) 4 (66.67) 8 (50.00) 0.646
Alcoholism, n (%) 0 (0.00) 1 (6.25) 1.000
Stroke, n (%) 0 (0.00) 2 (12.50) 1.000
T score 0.17 ± 0.41 0.27 ± 0.80 0.776
HR score 0.33 ± 0.82 0.25 ± 0.68 0.811
RR score 0.17 ± 0.41 0.07 ± 0.26 0.505
Shock, n (%) 5 (100.00)* 5 (38.46) 0.036
Na score 0.67 ± 1.03 0.00 ± 0.00 0.175
K score 0.67 ± 1.21 0.13 ± 0.35 0.334
Cr score 2.67 ± 1.51 1.43 ± 1.55 0.117
Hct score 0.67 ± 1.03 0.88 ± 1.26 0.722
WBC score 0.67 ± 1.03 0.75 ± 0.86 0.849
Bic score 3.33 ± 1.15 1.43 ± 0.79 0.015
FGSI score 7.67 ± 4.63 3.94 ± 3.51 0.052
Hospital stay, d 17.33 ± 12.76 21.59 ± 11.50 0.457
ICU stay, d 7.75 ± 6.24 3.60 ± 5.03 0.179
Operation times 2.40 ± 0.89 2.29 ± 1.21 0.859
Reconstruction, n (%) 2 (33.33) 3 (18.75) 0.585
*The data from one patient are missing.
Data are presented as mean ± standard deviation, unless otherwise indicated.
Bic ¼ bicarbonate; Cr ¼ creatinine; FGSI ¼ Fournier's Gangrene Severity Index;
Hct ¼ hematocrit; HR ¼ heart rate; ICU ¼ intensive care unit; K score ¼ potassium
score; Na ¼ sodium; RR ¼ respiratory rate; T score ¼ temperature score;
WBC ¼ white blood cell count.
Table 5
Association between risk factors and death from Fournier's gangrene.
OR 95% CI p
Diabetes 3.428 0.689e17.055 0.132
Hypertension 1.504 0.422e5.360 0.529
Alcoholism 3.667 0.744e18.079 0.111
Stroke 1.273 0.130e12.501 0.836
T score a 1.335 0.595e2.991 0.483
HR score 1.661 0.932e2.962 0.085
RR score 4.027 0.719e22.550 0.113
Shock b 45.000 5.154e392.869 <0.001***
Na score 1.286 0.654e2.527 0.466
K score 1.411 0.701e2.840 0.335
Cr score 2.013 1.301e3.112 0.002***
Hct score 1.016 0.555e1.862 0.958
WBC score 1.211 0.602e2.438 0.591
Bic score 2.286 1.046e4.998 0.038**
FGSI score  9 6.548 1.577e27.192 0.010***
Operation times 0.729 0.440e1.209 0.221
Reconstruction 0.322 0.065e1.602 0.166
**Indicates statistical signiﬁcance at p < 0.05.
***Indicates statistical signiﬁcance at p < 0.01.
Bic ¼ bicarbonate; CI ¼ conﬁdence interval; Cr ¼ creatinine; FGSI ¼ Fournier's
Gangrene Severity Index; Hct ¼ hematocrit; HR ¼ heart rate; K score ¼ potassium
score; Na ¼ sodium; OR ¼ odds ratio; RR ¼ respiratory rate; T score ¼ temperature
score; WBC ¼ white blood cell count.
a Per 1 score.
b Compared to without the event.
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21.1%, respectively; p ¼ 0.271) (Table 4).
Logistic regression analysis showed that the serum creatinine
score (OR ¼ 2.013, 95% CI ¼ 1.301e3.112), the bicarbonate score
(OR ¼ 2.286, 95% CI ¼ 1.046e4.998), a FGSI score of 9 or greater
(OR ¼ 6.548, 95% CI ¼ 1.577e27.192), and shock (OR ¼ 45.000, 95%
CI ¼ 5.154e392.869) were statistically signiﬁcantly associated with
death from FG (Table 5).4. Discussion
Fournier's gangrene has been described in children13,14, but FG
patients are usually aged 25e75 years. In agreement with the
results of other studies5, our results showed an overwhelming
male predominance (in 93.2% of cases). Nearly one-half of the
patients have no identiﬁable risk factors at diagnosis4; however, in
our series, patients who died had a worse renal function at pre-
sentation. This is in agreement with the ﬁndings of previous re-
ports that show that elevated serum creatinine levels are
associated with mortality12,15,16. Other reports also show an as-
sociation between mortality and other laboratory values such as
the hematocrit and the levels of serum albumin and serum alka-
line phosphatase12,16,17. In our study, an association between
mortality and the hematocrit was not demonstrated, and the
levels of serum albumin and alkaline phosphatase were not
evaluated. However, our study showed an association between the
bicarbonate level and mortality.Table 4
Comparison of the mortality rates between patients with a FGSI score of 9 or greater
and patients with a FGSI score of less than 9.
FGSI score  9 FGSI score < 9 p
Deaths overall, n (%) 5 (45.45) 7 (11.29) 0.014
Deaths in elderly patients, n (%) 2 (50.00) 4 (21.05) 0.271
FGSI ¼ Fournier's Gangrene Severity Index.Our study results conﬁrmed that the FGSI score was correlated
with death because a higher percentage of FG patients died who
had a FGSI score of 9 or greater. This is in agreement with the series
by Corcoran et al15, who showed that patients with a FGSI score of 9
or greater were 22 times more likely to die during their initial
hospitalization, compared to patients with a FGSI score of less than
9. Fournier's gangrene-related mortality is associated with a devi-
ation frommetabolic homeostasis due to the severity of disease and
the FGSI score can be used to assess this metabolic aberration;
therefore, the FGSI score can be used as an index of disease
severity18.
Previous studies report poorer outcomes in patients who were
older, debilitated, or had several comorbidities5,19. However, a
recent study showed that age and comorbidities do not affect
prognosis15. In our study, age and comorbidities such as hyper-
tension, diabetes mellitus, stroke, and alcoholism were not asso-
ciated with mortality.
Our results showed that elderly patients had longer ICU stays
and a greater number of the patients presented with shock. Shock
was also an important presenting factor associated with increased
risk of death. In our series, one-half of the patients who presented
with shock (5 of 10 elderly patients and 10 of 20 patients overall)
died of the disease. Therefore, special attention needs to be focused
on patients of any age presenting with shock.
In our series, roughly one-third of the FG patients were more
than 65 years old, but the mortality rate of these elderly patients
was twice as high as the rate in patients under 65 years old.
However, these differences between elderly patients and non-
elderly adults were not statistically signiﬁcant. This ﬁnding could
be because of the limited number of patients. Therefore, studies in a
larger cohort are necessary to conﬁrm these results.
5. Conclusion
This study showed that the clinical characteristics of elderly
patients were not signiﬁcantly different from those of younger
patients, and elderly patients did not have more severe disease at
presentation, as measured by the FGSI score. However, a signiﬁcant
Fournier's Gangrene in the Elderly 165percentage of elderly patients presented with shock, and most
patients who eventually died had shock at presentation. Therefore,
in addition to prompt surgical intervention and strong antibiotics,
we suggest intensive monitoring of vital signs and adequate car-
diovascular support, especially in the elderly.
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